Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
New York Genome Center | RCV001263411 | SCV001441455 | uncertain significance | Intellectual disability | 2020-02-06 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002491869 | SCV002800965 | uncertain significance | Mitochondrial complex 1 deficiency, nuclear type 9 | 2021-11-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002537658 | SCV003297541 | uncertain significance | not provided | 2022-09-13 | criteria provided, single submitter | clinical testing | This sequence change affects the initiator methionine of the NDUFS6 mRNA. The next in-frame methionine is located at codon 5. This variant is present in population databases (rs776323741, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with NDUFS6-related conditions. ClinVar contains an entry for this variant (Variation ID: 983422). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV002537658 | SCV005332666 | uncertain significance | not provided | 2024-03-04 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); Initiation codon variant in a gene for which loss of function is not a known mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge |